Disc Medicine, Inc.

US$78.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IRONHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR 42.97%
Div yield —
ROE (41.29%)
Biotechnology
Beta (5Y) 2.00
PE TTM —
TSR TTM (8.48%)
Mkt cap US$3.594B
ROIC (26.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$93
18.42%
18.68%
Hold 11|10|3|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.07
1.05
1.02
1.02
29.95%
26.97%
14.98%
5.38%
Revenue$M
207.7
208.2
206.3
203.4
(4.43%)
(4.30%)
(3.56%)
(3.95%)
Peers (US$3.594B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.148
0.485
0.416
EBIT/Intx
0.620
0.154
0.153
Own earn%
14.79
(167.37)
(162.31)
Sh yield%
33.26
35.97
35.07
Owners
Insiders/Inst%
4.60
41.06
Short interest%
5.19
SBC / revenue%
5.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
36–42
$1 testx
0.0
Incr. ROIC%
−1